01 1Sichuan Xieli Pharmaceutical
01 1CABAZITAXEL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-10-22
Pay. Date : 2021-08-25
DMF Number : 26462
Submission : 2012-09-18
Status : Active
Type : II
20
Sichuan Xieli Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CABAZITAXEL, with a corresponding US DMF Number 26462.
Remarkably, this DMF maintains an Active status since its submission on September 18, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2021, and payment made on August 25, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
